PBX1 antibody

Synonyms:PRL antibody
Catalogue No.:FNab06182Reactivity:Human, Mouse, Rat
Host:RabbitTested Application:ELISA, WB, IF, IP
Clonality:polyclonalIsotype:IgG
  • SPECIFICATIONS
Product Name
PBX1 antibody
Catalogue No.
FNab06182
Size
100μg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
Immunogen
Immunogen
pre-B-cell leukemia homeobox 1
Alternative Names
PRL antibody
UniProt ID
P40424
Observed MW
52 kDa
Application
Tested Applications
ELISA, WB, IF, IP
Recommended dilution
WB: 1:500-1:2000; IP: 1:200-1:1000; IF: 1:20-1:200
Validated Images
A2780 cells were subjected to SDS PAGE followed by western blot with FNab06182(PBX1 antibody) at dilution of 1:500
IP Result of anti-PBX1 (IP:FNab06182, 4ug; Detection:FNab06182 1:500) with A2780 cells lysate 1000ug.
Background
Binds the sequence 5'-ATCAATCAA-3'. Acts as a transcriptional activator of PF4 in complex with MEIS1. Converted into a potent transcriptional activator by the(1;19) translocation. May have a role in steroidogenesis and, subsequently, sexual development and differentiation. Isoform PBX1b as part of a PDX1:PBX1b:MEIS2b complex in pancreatic acinar cells is involved in the transcriptional activation of the ELA1 enhancer; the complex binds to the enhancer B element and cooperates with the transcription factor 1 complex(PTF1) bound to the enhancer A element. Probably in complex with MEIS2, is involved in transcriptional regulation by KLF4. Acts as a transcriptional activator of NKX2-5 and a transcriptional repressor of CDKN2B. Together with NKX2-5, it is required for spleen development through a mechanism that involves CDKN2B repression(By similarity).